EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Proceedings from the Third International Post-Tuberculosis Symposium: expanding the circle

B.W. Allwood, S.C. Auld, B. Beko, G.P. Bisson, C.P. Borges de Almeida, A. Byrne, F.C. Chow, A. Davis, S. Defres, M. Drage, D. Evans, X. Gai, G. Günther, A.N. Gupte, G. Hoddinott, M.A. Huaman, S. Huddart, J. Huynh, G. Kalyatanda, C. Khosa, T. Kutadza, G. Makanda, S. Marais, J. Meghji, N. Navuluri, E. Nkereuwem, A. Rajaratnam, K. Romanowski, I. Schoeman, J.A. Seddon, H. Sohn, F. Thienemann, D.T. Wademan, N.F. Walker, M.M. van der Zalm, R. Nightingale

IJTLD Open · 2025-12 · 2 (12) · 727-738

DOI: 10.5588/ijtldopen.25.0637 ↗
AbstractBibliografische Angaben

Abstract

SUMMARY In light of the recent growth in interest and knowledge of post-TB sequelae, there were high levels of engagement during the 3rd International Post-Tuberculosis Symposium held in Stellenbosch, South Africa. This multi-disciplinary symposium aimed to: 1) Advocate for greater global awareness of post-TB sequelae and empower TB-affected communities; 2) Advance knowledge by sharing current evidence and identifying key priorities; 3) Foster collaborations by strengthening research networks and developing concrete plans for research driven advocacy; and 4) Advance the field by establishing areas of consensus around diagnosis, care, and management. Guided by a 14-member Steering Committee, 9 academic working groups came together to develop key content for plenary sessions and facilitated workshops related to: Patient Engagement, Epidemiology and Modelling, Pathogenesis, Post-TB Lung Disease; Cardiovascular and Pulmonary Vascular Disease; Central Nervous System and Musculoskeletal Disease; Paediatrics Economic; Social and Psychological Sequelae; and Advocacy, Policy, and Stakeholder Engagement. Each group outlined progress within their respective fields and defined key priorities to focus discussion. The Symposium further catalysed coordinated action for the post-TB community of patients, advocates, clinicians, and researchers to define a clear path towards improving outcomes, reducing inequities, and ensuring TB survivors receive the care and support they deserve.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →